mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
Mitomycin-C |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |